PLIANT THERAPT (PLRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The depth of a $27trn market helps make Treasuries a haven; the dollar dominates trade in everything from goods and ...

The Punjab Congress on Wednesday staged a demonstration against the chargesheet filed by the Enforcement Directorate agai ...

Volkswagen’s all-new Tiguan R-Line has officially made its debut in India as a fully imported CBU. With its latest generation ...

Punjab Congress on Wednesday launched massive protests across the state, including at the Enforcement Directorate (ED) offices in Chandigarh and Jalandhar, expressing strong opposition to the chargesh ...

Donald Trump doubled down on his pro-Russia strategy on Monday, deflecting blame away from Moscow for deadly ballistic ...

My doctor wants me to hydrate more, but I find it difficult to drink the 64 ounces of water per day he recommends. I have a protein shake ...

Compound Growth at 16.42% Signals a New Phase of Network Automation Tool Market Expansion. MIDDLETON, Mass., /PRNewswire/ -- ...

Youngkin's role as a foot soldier in Trump’s tariff-fueled trade war may seem contradictory, given that he made his living – ...

Chandigarh/Jalandhar: Congress leaders and workers on Wednesday staged protests in Chandigarh, Jalandhar and Sirsa to show ...

Greenwald and Taibbi arrived at their journalistic celebrity through different paths. Greenwald, a civil libertarian and ...